Novel treatments in B cell non-Hodgkin's lymphomas | The BMJ
Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
New Approaches to the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Treatment resistance in diffuse large B-cell lymphoma | Leukemia
Biology Informs Treatment Choices in Diffuse Large B Cell Lymphoma: Trends in Cancer
Diffuse Large B cell lymphoma (DLBCL) - Lymphoma Australia
Limited-stage diffuse large B-cell lymphoma - ScienceDirect
Algorithm for decision-making for patients with diffuse large B-cell... | Download Scientific Diagram
New agents and regimens for diffuse large B cell lymphoma | Journal of Hematology & Oncology | Full Text
R-EPOCH May Extend Survival in Patients with Rare Forms of Diffuse Large B-Cell Lymphoma – Consult QD
Overall survival of patients with diffuse large B-cell lymphoma after... | Download Scientific Diagram
Diffuse Large B-Cell Lymphoma | NEJM
Diffuse Large B-Cell Lymphoma (DLBCL) | Aggressive B-Cell Non-Hodgkin's Lymphoma - YouTube
Diffuse Large B-cell Lymphoma Stages | RITUXAN HYCELA
Clinical approach to diffuse large B cell lymphoma - ScienceDirect
Evolution of therapy for limited stage diffuse large B-cell lymphoma | Blood Cancer Journal
JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma -5—diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS) | SpringerLink
Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options - ScienceDirect
Figure 2 from Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma | Semantic Scholar
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial - The Lancet Haematology
Frontiers | Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
